Skip to content

Eton Pharmaceuticals, Inc. ETON Other operating expenses

Other operating expenses at other companies

HRO
HarrowHROW
$49.13M+12.8%
PVL
Palvella TherapeuticsPVLA
$14.86M+88.7%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
-1.1%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$227.59M+10.6%
BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
$3.96M+303%
Arrowhead Research logo
Arrowhead ResearchARWR

Other financials

Income statement

See full
Revenue$24.3M+40.4%
Gross profit$14.7M+49.4%
Operating income$2.4M+614%
Net income$1.6M+199%
EPS (diluted)$0.05+183%

Balance sheet

See full
Cash & equivalents$19.7M+12.9%
Total debt$31.3M+3.7%
Total equity$30.6M+25.2%
Total assets$97.7M+16.3%

Cash flow

See full
Operating cash flow$7.4M+254%
CapEx$75.0K
Free cash flow$7.3M+251%

Valuation

See full
Market cap$930.79M+156%
Enterprise value$942.39M+150%
P/S10.7×+3.2×

Profitability

See full
Gross margin54.8%-3.7pp
Operating margin-15.1%
Net margin-9.5%-2.7pp
FCF margin17.1%

Returns & leverage

See full
Return on equity-34.2%+0.9pp
Debt / equity-0.2×
Current ratio1.2×-0.8×

Where this comes from

Reported directly by Eton Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The official record: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Eton Pharmaceuticals, Inc.'s other operating expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Eton Pharmaceuticals, Inc.'s other operating expenses?
Eton Pharmaceuticals, Inc. (ETON) reported other operating expenses of $12.32M in Q1 2026.
How has Eton Pharmaceuticals, Inc.'s other operating expenses changed year-over-year?
Eton Pharmaceuticals, Inc.'s other operating expenses increased by 19.3% year-over-year, from $10.33M to $12.32M.
What is the long-term trend for Eton Pharmaceuticals, Inc.'s other operating expenses?
Over 4 years (2021 to 2025), Eton Pharmaceuticals, Inc.'s other operating expenses has grown at a 20.7% compound annual growth rate (CAGR), from $20.54M to $43.58M.
What does other operating expenses mean?
Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.